PMID- 35625721 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230308 IS - 2227-9059 (Print) IS - 2227-9059 (Electronic) IS - 2227-9059 (Linking) VI - 10 IP - 5 DP - 2022 Apr 23 TI - Metformin Protects against Diabetic Cardiomyopathy: An Association between Desmin-Sarcomere Injury and the iNOS/mTOR/TIMP-1 Fibrosis Axis. LID - 10.3390/biomedicines10050984 [doi] LID - 984 AB - The intermediate filament protein desmin is essential for maintaining the structural integrity of sarcomeres, the fundamental unit of cardiac muscle. Diabetes mellitus (DM) can cause desmin to become dysregulated, following episodes of nitrosative stress, through the activation of the iNOS/mTOR/TIMP-1 pathway, thereby stimulating collagen deposition in the myocardium. In this study, type 2 diabetes mellitus (T2DM) was induced in rats. One group of animals was pre-treated with metformin (200 mg/kg) prior to diabetes induction and subsequently kept on metformin until sacrifice at week 12. Cardiac injuries developed in the diabetic rats as demonstrated by a significant (p < 0.0001) inhibition of desmin immunostaining, profound sarcomere ultrastructural alterations, substantial damage to the left ventricular tissue, collagen deposition, and abnormal ECG recordings. DM also significantly induced the cardiac expression of inducible nitric oxide synthase (iNOS), mammalian target of rapamycin (mTOR), and the profibrogenic biomarker tissue inhibitor of metalloproteinase-1 (TIMP-1). The expression of all these markers was significantly inhibited by metformin. In addition, a significant (p < 0.0001) correlation between desmin tissue levels/sarcomere damage and glycated hemoglobin, heart rate, iNOS, mTOR, and fibrosis was observed. These findings demonstrate an association between damage of the cardiac contractile unit-desmin and sarcomere-and the iNOS/mTOR/TIMP-1/collagen axis of fibrosis in T2DM-induced cardiomyopathy, with metformin exhibiting beneficial cardiovascular pleiotropic effects. FAU - Dawood, Amal F AU - Dawood AF AUID- ORCID: 0000-0001-7646-0909 AD - Department of Basic Medical Sciences, College of Medicine, Princess Nourah Bint Abdulrahman University, Riyadh 11671, Saudi Arabia. AD - Department of Physiology, Kasr al-Aini Faculty of Medicine, Cairo University, Cairo 12613, Egypt. FAU - Alzamil, Norah M AU - Alzamil NM AD - Department of Clinical Science, Family Medicine, College of Medicine, Princess Nourah Bint Abdulrahman University, Riyadh 11671, Saudi Arabia. FAU - Hewett, Peter W AU - Hewett PW AD - Institute of Cardiovascular Sciences, College of Medicine and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK. FAU - Momenah, Maha A AU - Momenah MA AUID- ORCID: 0000-0002-1827-0995 AD - Department of Biology, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh 11671, Saudi Arabia. FAU - Dallak, Mohammad AU - Dallak M AD - Department of Physiology, College of Medicine, King Khalid University, Abha 61421, Saudi Arabia. FAU - Kamar, Samaa S AU - Kamar SS AUID- ORCID: 0000-0002-9040-584X AD - Department of Medical Histology, Kasr al-Aini Faculty of Medicine, Cairo University, Cairo 12613, Egypt. FAU - Abdel Kader, Dina H AU - Abdel Kader DH AD - Department of Medical Histology, Kasr al-Aini Faculty of Medicine, Cairo University, Cairo 12613, Egypt. FAU - Yassin, Hanaa AU - Yassin H AD - Department of Physiology, Kasr al-Aini Faculty of Medicine, Cairo University, Cairo 12613, Egypt. FAU - Haidara, Mohamed A AU - Haidara MA AD - Department of Physiology, Kasr al-Aini Faculty of Medicine, Cairo University, Cairo 12613, Egypt. FAU - Maarouf, Amro AU - Maarouf A AD - Department of Clinical Biochemistry, Birmingham Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham B9 5SS, UK. FAU - Al-Ani, Bahjat AU - Al-Ani B AD - Department of Physiology, College of Medicine, King Khalid University, Abha 61421, Saudi Arabia. LA - eng GR - Princess Nourah bint Abdulrahman University, through the Research Funding Program, grant No (G18-00006)./King Abdul Aziz University Hospital/ PT - Journal Article DEP - 20220423 PL - Switzerland TA - Biomedicines JT - Biomedicines JID - 101691304 PMC - PMC9139128 OTO - NOTNLM OT - cardiomyopathy OT - desmin OT - diabetes OT - fibrosis OT - metformin OT - sarcomere COIS- The authors declare no conflict of interest. EDAT- 2022/05/29 06:00 MHDA- 2022/05/29 06:01 PMCR- 2022/04/23 CRDT- 2022/05/28 01:07 PHST- 2022/03/07 00:00 [received] PHST- 2022/04/09 00:00 [revised] PHST- 2022/04/20 00:00 [accepted] PHST- 2022/05/28 01:07 [entrez] PHST- 2022/05/29 06:00 [pubmed] PHST- 2022/05/29 06:01 [medline] PHST- 2022/04/23 00:00 [pmc-release] AID - biomedicines10050984 [pii] AID - biomedicines-10-00984 [pii] AID - 10.3390/biomedicines10050984 [doi] PST - epublish SO - Biomedicines. 2022 Apr 23;10(5):984. doi: 10.3390/biomedicines10050984.